Remove manufacturing moderna-biontechs-post-covid-futures-oncology-hit-manufacturing-realities
article thumbnail

Nine for 2022: innovation and opportunities in healthcare

pharmaphorum

However, what makes 2022 different in this respect is Big Tech’s positioning to ride the trends of healthcare digitisation, remote delivery and data utilisation, which have been started or accelerated by the COVID-19 pandemic. Medicine budget constraint, structural fund largesse. RNA Therapeutics come to the fore.

Vaccines 107